Adam Kittai, MD, is Associate Professor of Medicine (Hematology and Medical Oncology) with a clinical research focus on Non-Hodgkin Lymphoma, specifically CLL and Richter Transformation. As part of the lymphoma group, he is the Assistant Director of Lymphoma Clinical Research and the CLL Clinical Research Leader. Dr. Kittai has a strong background in clinical trials and population-based studies and has authored numerous publications in high impact journals including Blood and the Journal of Clinical Oncology. He was a 2018 ASH Research Training Award for Fellows awardee, and a 2022 recipient of the ASCO Conquer Cancer Career Development Award. He is a member of multiple national committees, including the ASH Committee on Training.